The company’s two globally recognised products Bio-Oss and Bio-Gide will aid in dental regeneration
Geistlich Pharma, a Swiss manufacturer of medical products, announced the commencement of its Indian operations, by establishing Geistlich Pharma India, a wholly-owned subsidiary and the 10th global affiliate. With this announcement, the two globally patented products Bio-Oss and Bio-Gide used for dental regeneration around the world will now be available across India.
Present on the launch in New Delhi, Paul Note, CEO, Geistlich Pharma said, “We are pleased to enter this dynamic and promising Indian market that has been showing a paradigm shift in its healthcare delivery mechanism. We are here not only at an opportune time, but I genuinely feel that Indian medical eco system is maturing and is increasingly receptive to best in class medical care. Our products supplement the patient’s complete dentistry – care requirements. In addition, we view India as a strategic fit for our business growth worldwide.”
Sandeep Ghavri, GM, Geistlich India, commented, “We see Geistlich Pharma India as a new process beginning in the Indian healthcare service industry. It is not just about being able to access a range of products with proven track record especially Bio-Oss and Bio-Gide, but also to leverage Geistlich’s vast experience and research of over 30 years in dental regeneration and 150 years of expertise handling natural tissues and bone. This is a new chapter in Indian dentistry, where the Indian people will now be aware of regenerative bio-material and the benefits they offer.”
EP News Bureau